Validation of Structured Light Plethysmography (SLPvsPNT)

July 7, 2018 updated by: Pneumacare Ltd

Validation of Structured Light Plethysmography Against Spirometry in Children and Adults

Measurements of Structured Light Plethysmography (SLP) using a chest wall movement based method will be compared to those obtained by spirometry using a flow based pneumotachograph method. This study will enable validation of SLP in children and adults by allowing direct comparison of simultaneous measurements of breathing sequences using the two measurement techniques.

The investigators will also examine, in a group of normal adults, repeatability of the agreement between the two devices, and whether the agreement is affected by a change in tidal breathing parameters.

Study Overview

Detailed Description

Measurements using the Structured Light Plethysmography method will be compared to those obtained by spirometry using a flow based pneumotachograph.

Spirometry is the gold standard for measuring lung function in both clinical support and research roles. Modern spirometers are high precision, reliable instruments enabling a large numbers of parameters relating to lung volumes and the rate of emptying the lungs during a forced expiration to be measured. The most common and accurate method to measure the patient's forced expiration is via pneumotachograph which measures the flow of air through a mouthpiece and integrates the signal to derive the volume expired.

Structured Light Plethysmography (SLP) system that measures changes of the chest and abdominal wall movement during breathing by modelling the thorax and abdominal surface defined by a projected structured light pattern which enables a grid of virtual parts to be formed, the movement of which is recorded by digital cameras. SLP provides non-contact assessment to provide lung function data utilising structured light technologies and enhanced imaging processing.

In this study direct comparison will be made of measurements recorded simultaneously using the two measuring devices in children and adults.

To examine repeatability of the agreement between tidal breathing parameters measured by two techniques, repeated measurements will be performed in each of a group of normal adult subjects. The investigators will also examine whether the agreement is affected by a change in tidal breathing parameters. To obtain a change in tidal breathing parameters, measurements will be recorded during resting spontaneous breathing and after a period of exercise to elevate Respiratory Rate.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cambridgeshire
      • Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ
        • Cambridge University Hospitals Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 78 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • For the patient group, any patient attending the outpatient department or the Lung Function Laboratory
  • For the Healthy Normals group, any adult between 18 and 80 years with no current or previous respiratory condition.

Exclusion Criteria:

  • A current cold or other viral infection
  • chest surgery within 4 weeks
  • Haemoptysis of unknown origin the (forced expiratory manoeuvre may aggravate the underlying condition)
  • Pneumothorax
  • Unstable respiratory or cardiovascular status (forced expiratory manoeuvre may worsen angina or cause changes in blood pressure) or recent myocardial infarction or pulmonary embolus
  • Recent eye surgery
  • Presence of an acute disease process that might interfere with test performance (e.g. Nausea, vomiting)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Breathing Sequence
Simultaneous measurement using Structured Light Plethysmography and Pneumotachograph Spirometry during a period of tidal breathing followed by a forced respiratory manoeuvre. This sequence is repeated twice.
Non contact device that uses light to record displacement of the anterior thorax and abdomen region
Other Names:
  • SLP
Device that measures airflow at the mouth using a mouthpiece
Other: Agreement and repeatability Breathing Sequence
Simultaneous measurement using Structured Light Plethysmography and Pneumotachograph Spirometry during a period of tidal breathing. This sequence is repeated one further time at rest, and once further time after an exercise test to elevate respiratory rate.
Non contact device that uses light to record displacement of the anterior thorax and abdomen region
Other Names:
  • SLP
Device that measures airflow at the mouth using a mouthpiece

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forced Vital Capacity (FVC) measured in Litres
Time Frame: 5 minutes
The volume of air a person can exhale during a maximal forced breath
5 minutes
Forced Expiratory Volume in one second (FEV1) measured in litres per second
Time Frame: 5 minutes
The volume of air a person can exhale in one second during a maximal forced breath
5 minutes
Peak Expiratory Flow (PEF) measured in litres per second
Time Frame: 5 minutes
The maximal flow a person can achieve during a maximal forced breath
5 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory Waveform
Time Frame: 5 minutes
Visual comparison of respiratory waveform shape and amplitude produced by pneumotachograph and SLP.
5 minutes
Respiratory Rate (RR) measured in seconds
Time Frame: 5 minutes
Tmings derived from the Respiratory Waveforms
5 minutes
Inspiratory Time (tI) measured in seconds
Time Frame: 5 minutes
Timings derived from the Respiratory Waveforms
5 minutes
Expiratory Time (tE) measured in seconds
Time Frame: 5 minutes
Timings derived from the Respiratory Waveforms
5 minutes
Total breath time (tTot) measured in seconds
Time Frame: 5 minutes
Timings derived from the Respiratory Waveforms
5 minutes
Inspiratory/expiratory ratio (tI/tE) expressed as a ratio
Time Frame: 5 minutes
Timing ratios derived from the Respiratory Waveforms
5 minutes
The duty cycle (tI/tTot) expressed as a ratio
Time Frame: 5 minutes
Timing ratios derived from the Respiratory Waveforms
5 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inspiratory over Expiratory flow at 50 percent of tidal displacement (IE50) expressed at a ratio
Time Frame: 5 minutes
Flow ratios derived from the Respiratory Waveforms
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Karl Sylvester, PhD, Addenbrookes University Hospitals NHS Trust

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2011

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

September 1, 2017

Study Registration Dates

First Submitted

November 3, 2015

First Submitted That Met QC Criteria

November 3, 2015

First Posted (Estimate)

November 5, 2015

Study Record Updates

Last Update Posted (Actual)

July 10, 2018

Last Update Submitted That Met QC Criteria

July 7, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CIP01/0010

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease

Clinical Trials on Structured Light Plethysmography

3
Subscribe